Elevated expression of androgen receptor, prostate specific antigen, cytokeratin 5, urokinase-type plasminogen activator and EphA2 correlated with dasatinib sensitivity in prostate cancer cell lines [14]. This evidence concerns the gene EPHA2 and Familial prostate cancer.